Carl Kraus
Director Técnico/Científico/I+D en AQUESTIVE THERAPEUTICS, INC. .
Fortuna: 756 000 $ al 31/05/2024
Cargos activos de Carl Kraus
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AQUESTIVE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 26/06/2023 | - |
i3 Research, Inc.
i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Carl Kraus
Antiguos cargos conocidos de Carl Kraus.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ACERAGEN, INC. | Director Técnico/Científico/I+D | 01/11/2021 | 30/04/2023 |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | Director Ejecutivo | 01/01/2017 | 31/10/2021 |
Presidente | - | 31/10/2021 | |
Fundador | 01/01/2015 | 31/10/2021 | |
Presidente | - | 31/10/2021 | |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Director Técnico/Científico/I+D | 28/09/2022 | - |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Director Técnico/Científico/I+D | 01/01/2007 | - |
Formación de Carl Kraus.
Washington University School of Medicine | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Chief Tech/Sci/R&D Officer | 5 |
Undergraduate Degree | 1 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 6 |
Commercial Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ACERAGEN, INC. | Health Technology |
AQUESTIVE THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
i3 Research, Inc.
i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Commercial Services |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Health Technology |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Carl Kraus
- Experiencia